Puma Biotechnology
PBYI
PBYI
171 hedge funds and large institutions have $4.39B invested in Puma Biotechnology in 2017 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more call options, than puts
Call options by funds: $87.1M | Put options by funds: $74M
11% more funds holding
Funds holding: 154 → 171 (+17)
2.49% more ownership
Funds ownership: 96.09% → 98.59% (+2.5%)
Holders
171
Holding in Top 10
12
Calls
$87.1M
Puts
$74M
Top Buyers
| 1 | +$218M | |
| 2 | +$78.6M | |
| 3 | +$48.3M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$43.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.9M |
Top Sellers
| 1 | -$203M | |
| 2 | -$118M | |
| 3 | -$95.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.6M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$37.4M |